The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: Molecular staging of prostate cancer

British Journal of Urology

Volumn 77, Issue 3, 1996, Pages 411-417

  Olsson, C A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Prostate cancer; Prostate specific antigen; RT PCR; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029926936     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.90616.x     Document Type: Article

References (19)

1. Rifkin MD, Zerhouni EA, Gatsonis ÇA et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 1990; 323: 621-6
2. Salo JO. Kivisarri L, Rannikko S, Lehtonen T. Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic carcinoma before radical retropubic prostatectomy. J Urol 1987; 137: 435-8
3. Hricak H, Dooms GC. Jeffery RB et al. Prostatic carcinoma: staging by clinical assessment. CT. and MR imaging. Radiology 1987: 162: 331-6
4. Partin AW. Pound CR. Clemens JO. Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 1993; 20: 713-25
5. Zincke H. Oesterling JE. Blute ML. Bergstralh EJ, Myers RP. Berrett DM. Long term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850-7
6. Mukamel E. Hanna J. deKernion JB. Pitfalls in preoperative staging in prostate cancer. Urology 1987; 30: 318-23
7. Katz AE, Olsson ÇA. Raffo AJ et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994: 43: 765-75
8. Katz AE. de Vries GM. Begg MD et ni. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995; 75: 1642-7
9. Horoszewicz JS, Leong SS. Kawinski E et al. LnCaP model of human prostatic carcinoma. Cancer Res 1983: 43: 1809-17
10. Bostwick DG. Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. Am J Clin Pathol 1994; 102: S31-7
11. Aihara M. Lebovitz RM. Wheeler TM, Kinner BM. Ohori M. Scardino PT. Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer. J Urol 1994; 151: 1558-64
12. Sokoloff M. Tso C. Kaboo R et al. Super-sensitive and quantitative polymerase chain reaction (PCR): an innovative technique for staging and monitoring prostate cancer. J Urol 1995: 153: 294A
13. Israeli RS. Miller WH Jr. Su SL et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostatespecific membrane antigen and prostate-specific antigenbased assays. Cancer Res 1994: 54: 6306-10
14. Yu H. Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 1995: 270: 6615-8
15. Yu H. Giai M. Diamandis EP et ni Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995: 55: 2104-10
16. Monne M. Croce CM. Yu H. Diamandis EP. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 1994; 54: 6344-7
17. Smith MR. Biggar S. Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 1995; 55: 2640-4
18. Scaletscky R. Koch MO. Eckstein CW. Bicknell SL, Gray GF Jr. Smith JA Jr. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J Vrol 1994; 152: 129-31
19. Epstein JI, Pizov G. Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993: 71: 3582-93